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Background 
In an effort to elevate its laboratory science and safety programs, the Centers for Disease Control and 
Prevention (CDC) sought internal and external input on strategies to mitigate laboratory safety concerns. The 
External Laboratory Safety Workgroup (ELSW) of the Advisory Committee to the Director (ACD), CDC, was 
formed to provide an external perspective of how CDC could improve laboratory science and safety within 
the agency. Members of the ELSW are subject matter experts in the fields of biosafety, laboratory science, 
and research. In 2014, they reviewed CDC’s policies and procedures related to laboratory safety and quality, 
visited CDC laboratories, conducted a laboratory safety culture survey, and engaged CDC staff and 
leadership. In culmination of these activities, the ELSW reported their findings to the Advisory Committee to 
the Director (ACD). The ACD provided recommendations to enhance best practices in laboratory safety and 
quality within CDC.  
CDC concurred with these recommendations and immediately began implementing them. This report 
addresses progress in implementation of laboratory science and safety initiatives made by CDC to address 
the ADC’s recommendations and those from other internal and external reviews. Through this work, CDC's 
aim is to improve the culture of laboratory safety across the agency and minimize the risks associated with 
laboratory work. 
Previously Reported Progress  
On April 23, 2015, the CDC reported its progress toward addressing ACD’s recommendations and on other 
laboratory safety improvements being implemented at the agency. Key activities included: 
July 2014  CDC imposed a moratorium on transfers of biological material out of BSL-3 and BSL-4 
laboratories 
Sep. 2014 Completed “Clean Sweep” for biological select agents and toxins 
Oct. 2014 Moratorium resolution for 52 BSL-3 and BSL-4 laboratories completed 
Jan. 2015 Standardized disinfection practices across CDC’s infectious diseases laboratories 
Feb. 2015  CDC enhanced its custodianship of specimen procedures with new onboard and offboard 
instructions 
March 2015 CDC rolled out a new electronic specimen inventory management system 
March 2015 CDC completed a self-initiated biological specimen inventory 
April 2015 CDC updated the Select Agent Incident Response Plan to include specific decontamination 
procedures to follow in the event of a release; it was implemented in all 13 CDC select agent-
registered laboratories working with live agents. 
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ACD Recommendations and CDC’s Most Recent Progress 
Since April, CDC has continued to make progress towards implementing strategies aimed at addressing the 
ADC’s recommendations. Most importantly, a permanent, single point of accountability for laboratory science 
and safety has been appointed to lead these efforts.  
Leadership 
Create a biomedical scientist position in the Director’s office to lead laboratory science and 
safety efforts and support the agency’s laboratory scientists 
Dr. Steve Monroe was named the Associate Director for Laboratory Safety and Science (ADLSS) in 
September 2015. In this role, he will provide agency-wide leadership and accountability for laboratory 
science, safety, and quality. A priority for Dr. Monroe is to engage with and advocate for CDC’s laboratory 
scientists. Throughout the month of October, he reached out to laboratory leadership from each laboratory-
containing division to receive input on initiatives and improvements to laboratory safety and science. He and 
his office (OADLSS) will use the information received from these meetings to inform future communications 
with CDC’s laboratory programs and to promote their important public health work. 
A laboratory All-Hands meeting will occur October 30, 2015. This forum will provide the OADLSS an 
opportunity to communicate the ACD’s findings with laboratory staff, review key OADLSS initiatives, and 
provide laboratory staff an opportunity to provide feedback and ask questions. Over the next year, Dr. 
Monroe will meet with bench-level laboratory staff from each laboratory branch at CDC to better understand 
the breadth of work conducted at the agency, provide value-added resources for their everyday work, and 
strengthen relationships with CDC’s laboratory community. 
Establish and communicate a “CDC Way” regarding responsible, safe science and improve 
mechanisms for sharing information about safety incidents 
Laboratory safety is a top priority for CDC’s Director and its leadership. In order to increase uniformity of 
incident notification, CDC updated its procedures for prompt reporting of laboratory incidents. On July 20, 
2015, CDC laboratory safety leadership distributed a Laboratory Infectious Agent Exposure Risk Assessment: 
Response and Notification Flow Chart. Leadership from OADLSS and CDC’s Office of Safety, Security, and 
Asset Management (OSSAM) held a follow-up forum on August 21, 2015, to answer questions concerning 
the updated notification system. In response to feedback received at that forum, OADLSS has been 
collaborating with OSSAM to update its internal website to include incident reporting FAQs, provide examples 
of “near miss” scenarios, and revise the incident notification flow chart to increase clarity for notification 
responsibilities of the affected individuals and their supervisors. 
Consider laboratory safety programs and training as a fundamental mission for CDC and 
establish central funding source for these activities 
CDC sought funding to further enhance laboratory science, safety, and training initiatives at the agency. 
Central funding for laboratory safety and training programs was established in fiscal year 2015. The fiscal 
year 2016 President’s Budget requested an additional $20 million to build CDC’s laboratory safety capacity.  
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Governance 
Establish a central entity at the level of the Office of the Director for accountability and 
oversight authority for laboratory safety and compliance committees 
OADLSS serves as the central entity for accountability and oversight authority for laboratory safety and 
compliance committees. In this capacity, it is the governing office for the Institutional Biosecurity Board 
(IBB), Institutional Biosafety Committee (IBC), and the Laboratory Safety Review Board (LSRB), providing 
both administrative support and scientific guidance to the various boards and committees. OADLSS will hold 
a retreat with these three boards and committees to jointly outline how they will interact and be supported 
by OADLSS. The Institutional Animal Care and Use Committee (IACUC) continues to report to the Office of the 
Associate Director for Science (OADS), also in CDC’s Office of the Director.  
In addition to supporting these review boards, OADLSS is now responsible for reporting all Dual-Use 
Research (DUR) and Dual-Use Research of Concern (DURC)-related research to the Department of Health 
and Human Services (HHS). CDC leadership is currently assessing whether organizational improvements or 
realignments will further enhance biosafety in the agency.  
Risk Assessments 
Establish a centralized, standardized mechanism for consistent and thorough review and 
risk assessment of proposed research activities 
CDC’s Laboratory Safety Review Board (LSRB) is a new centralized board formed with the purpose of 
standardizing review of high-risk research activities. This board was established in lieu of an IBC expansion 
to conduct reviews and risk assessments. The LSRB, comprised of laboratory science experts from across 
the agency, reviews and approves all protocols for the inactivation and transfer of biological materials from 
BSL-3 and BSL-4 laboratories to those of lower containment. The LSRB also issues guidance and 
recommendations for biosafety training related to inactivation protocols.  
Risk assessments should be performed and documented before experimental work is done 
OADLSS has developed new agency-level policy to require the use of risk assessments for experimental 
work. A new biological risk assessment course has been created for CDC staff. This monthly course trains 
scientists to identify risks associated with laboratory procedures involving work with biological agents. A 
post-training evaluation was also administered to assess competency of students and program 
implementation effectiveness. To date, the course has been offered 10 times with a total of 161 laboratory 
and support staff trained, representing a majority of laboratories that work with biological select agents and 
toxins at the agency.  
 
Training 
Establish a standardized lab safety training curriculum with methods for competency skills 
mapping and refresher training 
OADLSS has established a core safety training curriculum. In January 2015, the Biosafety Training Work 
Group (now the Laboratory Safety Training Board) identified and documented competencies for core safety 
training. They reviewed 23 existing safety trainings at CDC, mapping competencies and identifying gaps in 
knowledge. The BTWG developed a prioritized list of courses for development of a standard safety training 
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curriculum, developing learning objectives for these primary courses, and finalized an implementation plan 
for rollout of competency-based, core safety training across CDC.  
CDC subject matter experts (SMEs) were engaged with the development of these biosafety training 
materials. In September, OADLSS hosted a SME forum to present timelines for roll-out, roles and 
responsibilities; the importance of SMEs in the creation of standardized biosafety training was also 
emphasized. The first four courses are nearing completion and will be released this calendar year.  
OADLSS has procured a contract for and will conduct an external review of CDC’s entire curriculum 
development process to identify lessons learned and opportunities for improvement. 
Establish a fellowship program to train scientists to serve as laboratory safety professionals 
The Laboratory Leadership Service (LLS) was formed in 2014 as a program designed to train scientists to 
serve as leaders and safety professionals. The fellowship combined core public health laboratory 
competency-based coursework with practical, applied research and service. The first class of fellows began 
their two-year commitment on July 1, 2015. Finalists for the 2016 LLS class and host laboratories have been 
selected. Currently, finalists are being interviewed by potential host laboratories to establish a good match 
between the two groups. Lessons learned from the 2015 class will inform revisions and improvements to the 
curriculum for next year.  
Responsibilities and facilities for lab safety training should be in-house 
OADLSS has made concentrated efforts to house responsibilities and facilities for laboratory safety training 
within the agency. The office initiated the development of a standardized biosafety training curriculum, 
identified funding for development of a new general laboratory safety training curriculum, and developed a 
proposal for a new state-of-the-art laboratory training center. If funding is identified, the new laboratory 
training center will be designed to provide hands-on training for laboratory staff across the CDC.  
OADLSS established the Laboratory Safety Training Board to review laboratory safety training materials for 
regulatory compliance and best practices. This chartered group serves as the governing body for CDC’s 
laboratory safety training curriculum. The board’s first meeting took place in October 2015.  
Culture of Safety and Incident Notification 
Establish a culture of responsible science and accountability 
 
Recognizing that prompt incident notification is a key part of laboratory safety efforts, OADLSS has 
implemented enhanced procedures for swift and easy reporting. The office created the Lab Safety Helpdesk, 
which allowed reporting of safety issues and requests for safety service. Staff are also able to report issues 
and concerns anonymously, if they choose to do so. 
CDC also updated their procedures for prompt reporting of potential biological agent exposure related 
laboratory incidents. On July 20, 2015, CDC laboratory safety leadership distributed a Laboratory Infectious 
Agent Exposure Risk Assessment: Response and Notification Flow Chart. Leadership from OADLSS and 
OSSAM held a follow-up forum on August 21, 2015, to answer staff questions concerning the updated 
notification system. In response to feedback received at that forum, OADLSS has been collaborating with 
OSSAM to update its website to include incident reporting FAQs and revise the incident notification flow 
chart to increase clarity for notification responsibilities of the involved individuals and their supervisors. 
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OADLSS and OSSAM will also work together to provide examples and develop guidance concerning “near 
misses.” In order to identify trends, it is important for the office to capture “near misses” to analyze these 
non-events. This analysis can provide insight into potential laboratory safety issues that have not yet reached 
a critical point.  
Report and analyze incidents and corrective actions; share lessons learned with the 
community 
OADLSS provides progress updates related to CDC’s major laboratory incidents in 2014 on its internal and 
external websites. OADLSS also alerts staff and provides remediation instructions to laboratory staff 
following laboratory incidents and near misses through the CDC laboratory list serve. This provides a 
transparent mechanism that details how CDC and OADLSS responds to laboratory safety incidents.  
CDC has ongoing partnerships with other federal agencies, including FDA and NIH, to share best practices 
around lab safety and leverage resources among the agencies.  OADLSS leadership has presented on its lab 
safety practices at scientific meetings and will continue to seek additional opportunities for collaboration.  
OADLSS will continue to engage the Division of Select Agents and Toxins (DSAT) about potential implications 
for select-agent regulated entities. 
Ensure scientists operating safe laboratories are recognized for their work 
OADLSS implemented a new program called the Laboratory Safety Champion, which recognizes staff who 
promote laboratory safety and best practices through stories on CDC Connects, CDC’s internal news site. To 
date, five laboratory scientists and engineers have been recognized in this way. OADLSS intends to highlight 
new laboratory staff each month in order to promote good laboratory safety and quality standards.  
The laboratory e-mail distribution listserv reaches more than 1600 staff; OADLSS uses this medium to 
congratulate staff who demonstrate responsible and safe actions in their laboratories. The Office also hosted 
a Laboratory Safety Innovation Championship designed to recognize innovative laboratory safety solutions. 
This fall, OADLSS will also begin recognizing teams of laboratory scientists who demonstrate a culture of 
excellent laboratory science and safety through CDC Connects stories.  
OADLSS is currently developing an internal grant mechanism to award funding for innovative laboratory 
safety solutions with the potential for implementation throughout CDC laboratories.  
Biosafety and Occupational Medicine 
Raise the stature of ESHCO through hiring of additional scientific staff 
CDC has developed new standard position descriptions for Laboratory Quality Management and 
Safety and Occupational Health Specialists to accelerate staffing the Environment, Safety, and 
Health Compliance Office (ESHCO) with scientists who have professional biosafety qualifications. 
Organizational improvements to increase the efficiency of CDC laboratory facility oversight are 
being proposed. 
Appoint Division liaisons to represent the programs’ needs to a centralized ESHCO 
committee 
OADLSS identified a representative from each of the infectious disease centers to represent program needs 
related to safety consultations and risk assessments to ESHCO. The office also developed new position 
descriptions for safety and occupational health managers at several levels to create a mechanism for 
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programs to hire safety experts. Going forward, OADLSS will convene a panel to address progress toward 
safety concerns and standardization of safety practices across laboratories.  
Expand the scope and capabilities of the Occupational Medicine Program to facilitate active 
monitoring of employee health and ability to respond to laboratory incidents 
CDC requested assistance from the Federal Occupational Health to conduct an assessment of clinic 
operations; implementing improvements now, with a follow-up review pending.  CDC also 
established an internal health advisory group to review and improve operations, leading to new 
procedures to enhance the Occupational Health Clinics’ capacity for monitoring employee health, 
including hiring a clinic administrator.  
Progress Reporting 
Track and report progress in establishing programmatic elements and recommended 
processes   
OADLSS provides on-going updates on progress towards addressing internal and external recommendations. 
They provide verbal regular updates to the external Laboratory Safety Workgroup (ELSW) in addition to 
formal updates to the ACD on April 23, July 17, and October 29, 2015. CDC also provides monthly updates 
to HHS, reporting on progress. In addition to these groups, OADLSS posts regular written updates on its 
website. 
External Accreditation 
Pursue external review and accreditation for CDC laboratories 
In 2015, OADLSS initiated a pilot program with five infectious diseases laboratories to attain external 
accreditation to International Organization for Standardization (ISO) standards. The purpose of this pilot is to 
assess best practices and apply lessons learned for implementation across the agency. Key activities of this 
pilot have included: (1) conducting stakeholder engagement sessions to solicit input and recommendations; 
(2) conducting training for pilot laboratories in ISO 17025 standards and in internal auditing techniques; and 
(3) conducting several benchmarking interviews and eleven site visits with ISO-accredited government 
laboratories. Following these activities, the OADLSS completed a gap analysis comparing the Infectious 
Diseases Laboratory Quality Manual to ISO 17205 requirements and is drafting a template Quality Manual 
for use by the pilot laboratories. Next steps for the pilot include reviewing and implementing the Quality 
Manual Template, developing documentation for the Quality Management System, and implementing ISO 
17025 processes and procedures in pilot laboratories.  
